FindTrial
Sign In

Optive

DRUG10 trials

Sponsors

Innovative Medical, Bp Consulting, Inc, Alcon Research, Gina Rogers, Laboratoires Thea

Conditions

Comfort, Vision and Wear TimeDiabetic RetinopathyDry EyeDry Eye SyndromeDry Eye SyndromesMacular DegenerationMyopia, DegenerativeRetinal Artery Occlusion

Phase 3

A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
CompletedNCT02871440
The University of New South WalesDry Eye Syndromes
Start: 2016-09-19End: 2017-09-18Updated: 2020-05-12

Phase 4

A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye
CompletedNCT00399230
Innovative MedicalDry Eye
Updated: 2007-08-21
Refractive Surgery and Optive Compatibility Study
CompletedNCT00469157
Innovative MedicalDry Eye Syndromes
Start: 2007-05-31End: 2008-04-30Updated: 2008-04-17
Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses
CompletedNCT00570843
Bp Consulting, IncComfort, Vision and Wear Time
Start: 2008-03-31End: 2010-02-28Target: 50Updated: 2010-02-22
Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye
CompletedNCT00724412
Alcon ResearchDry Eye
Start: 2008-04-30End: 2009-02-28Updated: 2012-02-02

Unknown Phase

Evaluation of SYSTANE Ultra Lubricant Eye Drops
CompletedNCT00702377
Alcon ResearchDry Eye
Start: 2008-06-30End: 2008-09-30Updated: 2012-02-02
Tears Substitutions and Their Effects on Higher Order Aberrometery
WithdrawnNCT00812721
Gina RogersDry Eye Syndrome
Start: 2009-01-31End: 2009-07-31Updated: 2017-04-04
Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time
WithdrawnNCT01417013
Alcon ResearchDry Eye
Start: 2011-07-31End: 2012-01-31Updated: 2012-02-08
Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome
TerminatedNCT02617095
Laboratoires TheaDry Eye Syndrome
Start: 2015-02-28End: 2016-10-31Updated: 2017-03-08
Ocular Discomfort Assessment After Intravitreal Injections
CompletedNCT02806830
Centre Hospitalier Intercommunal CreteilDiabetic Retinopathy, Macular Degeneration, Myopia, Degenerative +1
Start: 2016-04-30End: 2017-07-01Updated: 2017-07-28